Cloning, expression, and pore-forming properties of mature and precursor forms of pleurotolysin, a sphingomyelin-specific two-component cytolysin from the edible mushroom Pleurotus ostreatus

Biochimica Et Biophysica Acta
Nobuki SakuraiToshio Tomita

Abstract

Pleurotolysin, a sphingomyelin-specific cytolysin consisting of A (17 kDa) and B (59 kDa) components from the basidiomycete Pleurotus ostreatus, assembles into a transmembrane pore complex. Here, we cloned complementary and genomic DNAs encoding pleurotolysin, and studied pore-forming properties of recombinant proteins. The genomic regions encoding pleurotolysin A and B contained two and eight introns, respectively, and putative promoter sequences. The complementary DNA (cDNA) for pleurotolysin A encoded 138 amino acid residues, and the predicted product was identical with natural pleurotolysin A, except for the presence of the first methionine. Recombinant pleurotolysin A lacking the first methionine was purified as a 17-kDa protein with sphingomyelin-binding activity. The cDNA for pleurotolysin B encoded a precursor consisting of 523 amino acid residues, of which N-terminal 48 amino acid residues were absent in natural pleurotolysin B. Mature and precursor forms of pleurotolysin B were expressed as insoluble 59- and 63-kDa proteins, respectively, which were unfolded with 8 M urea and refolded by 100-fold dilution with 10 mM Tris-HCl buffer, pH 8.5. Although neither recombinant pleurotolysin A nor B alone was hemolytically act...Continue Reading

References

Jul 4, 1979·Biochimica Et Biophysica Acta·A W Bernheimer, L S Avigad
Jan 1, 1985·European Biophysics Journal : EBJ·H U WilmsenG Boheim
Jun 12, 1986·Biochimica Et Biophysica Acta·A W Bernheimer, B Rudy
Jan 1, 1987·Reviews of Physiology, Biochemistry and Pharmacology·S Bhakdi, J Tranum-Jensen
Nov 15, 1974·Nature·J Y LinT W Jeng
Sep 13, 1983·Biochemistry·H FaulstichJ Seitz
Oct 1, 1996·Biological & Pharmaceutical Bulletin·Y FukuchiK Yokota
May 22, 2002·Biochimica Et Biophysica Acta·Sabina BerneKristina Sepcić
Jan 1, 2003·Biochimica Et Biophysica Acta·Michelle Montoya, Eric Gouaux
Aug 2, 2003·Toxicon : Official Journal of the International Society on Toxinology·Michael W Parker

❮ Previous
Next ❯

Citations

Mar 31, 2010·Infection and Immunity·Lacey D TaylorHarlan D Caldwell
Jul 10, 2012·Medical Mycology·Ajay P NayakDonald H Beezhold
Dec 21, 2010·Developmental and Comparative Immunology·Shu ZhangMichael R Strand
Sep 8, 2010·Toxicon : Official Journal of the International Society on Toxinology·Taisei ShibataKazuo Miyairi
Oct 27, 2015·Biochimica Et Biophysica Acta·Akiko Yamaji-HasegawaToshihide Kobayashi
Aug 30, 2008·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Hui LvJin-Ku Bao
May 6, 2008·Toxicon : Official Journal of the International Society on Toxinology·Helena H ChowdhuryKristina Sepcić
Nov 27, 2015·Biochimica Et Biophysica Acta·Cyril F ReboulMichelle A Dunstone
Aug 14, 2009·The New Phytologist·Quoc Truong HoangJeong Sheop Shin
Mar 20, 2016·Biochimica Et Biophysica Acta·Takuma KishimotoToshihide Kobayashi
Apr 1, 2006·Progress in Lipid Research·Richard M Epand
Feb 6, 2015·PLoS Biology·Natalya LukoyanovaMichelle A Dunstone
Aug 7, 2013·Journal of Lipid Research·Hema Balakrishna BhatToshihide Kobayashi
Nov 18, 2017·Journal of Molecular Microbiology and Biotechnology·Gabriel Moreno-HagelsiebMilton H Saier
Feb 22, 2014·The Journal of Biological Chemistry·Sarah E StewartPhillip I Bird
Jul 16, 2010·Mycopathologia·Ajay P NayakDonald H Beezhold
May 1, 2021·Membranes·Maja GrundnerMatej Skočaj

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.